ILTS REAL: Liver Transplantation for Hepatocellular Carcinoma in countrieswith low donation rate.

Date: March 28, 2022

Time: 8 PM GMT-3

Join the fourth REAL webinar for Latin America in collaboration between ILTS and ALEH (Asociación Latinoamericana para el Estudio del Hígado) on March 28th, 2022. A first-class roundtable panel will discuss the current state of Liver Transplantation for Hepatocellular Carcinoma in Latin America.

Objectives

• To present data on the current state of Liver Transplantation for Hepatocellular Carcinoma in Latin America.
• To discuss strategies for countries with low donation rate (unrelated living donor, immunosuppression strategies, new criteria, etc.)

REGISTER FOR FREE

Organizers

	Juan Pablo Arab, Professor of Medicine at the Pontificia Universidad Catolica de Chile School of Medicine. Trained at the Pontificia Universidad Catolica, Chile and Mayo Clinic, Rochester, MN, USA. Dr. Arab is a Transplant Hepatologist and Physician Scientist with interest in translational and clinical research in alcohol-related liver disease and non-alcoholic fatty liver disease. He is the Director for Living Donor Liver Transplantation at his institution. He has published more than 100 peer-reviewed papers on gastrointestinal and liver diseases in high-impact factor journals, several book chapters and delivered lectures at national and international meetings. He is the Vice-President of the Chilean Hepatology Association and a member of the Education & Scholarship Committee of the International Liver Transplantation Society (ILTS).
	Roberto Hernandez-Alejandro is Chief of the Division of Transplantation at the University of Rochester (URMC) since August 2016. There, he’s demonstrated his ability to grow a program, leading his team to double the number of organ transplants with the best outcomes in the program’s history. Under his leadership, URMC restarted live donor liver transplants, performing 30 operations over 2.5 years as well as introducing a very active program of donation after cardiac death. Dr. Hernandez is also heavily focused on liver resections and is one of a handful of US surgeons performing the ALPPS procedure. Dr. Hernandez recently opened the second active program on liver transplantation for unresectable colorectal liver metastases in the US. Dr. Hernandez has received multiple grants for innovative research in liver cancer and regeneration and has >100 peer-reviewed publications in HPB and liver transplantation. In 2019, he joined the editorial board of Annals of Surgery, the highest impact factor surgical journal. Dr. Hernandez has positions in many societies, including the Scientific Committee of the ALPPS Registry, Chair of the ILTS Education & Scholarship Committee, and President of the New York Liver Transplant Consortium.
	Rodrigo Zapata is a Professor of Medicine, Universidad del Desarrollo, Santiago, Chile. Transplant hepatologist and chief of Gastroenterology at Clínica Alemana de Santiago. He completed an AASLD clinical Fellowship in Hepatology and Liver Transplantation at the University of Southern California (USC) in 2000-2001. He served as the President of the Chilean Association for the Study of the Liver (2008-2010), President of the Chilean Society of Gastroenterology (2012-2014), and International Member of the Global Guidelines Committee of the WGO (2015-2018). His main clinical interests are in liver transplantation, viral hepatitis, and hepatocellular carcinoma, with > 80 peer-reviewed publications and chapters of textbooks, as author or co-author. Currently, coordinator of the Special Interest Group (SIG) for Liver Transplantation of the ALEH (Asociación Latinoamericana para el Estudio del Hígado).
	Manuel Mendizabal currently works as a hepatologist at the Hepatology and Liver Transplantation Unit of the Austral University Hospital in Buenos Aires. He received his medical degree from Austral University and completed his Internal Medicine residency at the same Institution. He subsequently completed his training in Hepatology and Liver Transplantation at the University of Pennsylvania under the direction of Dr. Rajender Reddy. He is part of the different regional scientific societies, being currently the Secretary of the Latin American Association for the Study of the Liver (ALEH) and the Secretary of the Argentine Society for the Study of Liver (SAHE). His areas of interest are viral hepatitis, acute liver failure, and liver transplantation having more than 90 publications in scientific journals and book chapters.

Moderator

Josefina Pagés, MD., is a medical doctor graduated from the Austral University, Argentina in 2010. She completed her Intensive Care residency at the Austral University Hospital and between 2016-2018 she completed her training in Hepatology and Liver Transplantation at the same hospital. She has been a specialist since 2018. In 2019 she served as Chief Resident of the Hepatology and Liver Transplantation service. Since then, she has been working at the Austral Hospital as a staff doctor in the Hepatology and Liver Transplant Unit. Between 2019 and 2020, she completed a Master’s Degree in Clinical Effectiveness with a focus on Health Technology Assessment. She is part of the multiple regional scientific societies and is currently the Argentine representative of the Liver Transplantation interest group and coordinator of the Cirrhosis interest group of the Latin American Association for the Study of the Liver (ALEH). Dr. Pages has a strong academic vocation, her main areas of interest are advanced liver disease, acute liver failure and liver transplantation.

Presenter

Federico Piñero MD, Msc, PhD. Physician specialized in Internal Medicine, Hepatology and Liver Transplantation. Actually working at the Austral University Hospital, Buenos Aires. Argentina. Clinical researcher focused on hepatocellular carcinoma. Has a wide experience in Clinical Research, has participated as sub-investigator in different clinical trials and has published more than 30 researches indexed in Pubmed-Medline as first or corresponding author. Masters Science in Clinical Epidemiology and Research for Public Health from the University of Buenos Aires (MSCE) and has defended his PhD thesis with outstanding performance. Current alumni of the Harvard Medical School´s Leadership in Global Clinical Scholars Research Training Program 2021-2022 (GCSRT). Has presented several clinical researches at international liver meetings, achieving some international awards. Has won two National grants from the Argentine Institute of Cancer focusing on microbiome and liver cancer. He is member of the Editorial Board and has reviewed different researches from several indexed Journals. He is now regional coordinator of hepatocellular cancer of the Latin American Association for the Study of Liver Diseases (ALEH), and Board member of the Education Committee from the International Liver Cancer Association (ILCA). Coordinator of the Epidemiology and Clinical Research Section of the Academic Department from the Austral University Hospital.

Roundtable

Panelists

	Jorge Marrero, MD, MS, (CRDSA), MSHCM. A nationally and internationally recognized gastroenterologist and hepatologist, Chief and T. Grier Miller Professor of Medicine at Penn Gastroenterology and Hepatology. A leader in the field of advanced liver disease and transplant hepatology. Dr. Marrero is an expert in liver transplantation for patients with hepatocellular carcinoma. His specialties include liver disease, gastroenterology, digestive diseases and internal medicine. Dr. Marrero received his medical degree from the Ponce School of Medicine in Ponce, PR. He completed his internal medicine residency at the Medical College of Pennsylvania (now the Drexel University College of Medicine) in Philadelphia, and completed a gastroenterology and hepatology fellowship at the University of Illinois College of Medicine at Chicago.
	Blanca Norero, MD. Gastroenterology and Hepatology. Dr. Norero completed GI and Hepatology fellowship in Pontificia Universidad Católica de Chile (2010-2012), Santiago, Chile. CAS/DAS Hepatology at the Inselspital, Bern, Switzerland (2020-2021). Member of the Chilean Hepatology Association. Part of the Editorial group of Revista Medica de Chile. Currently works as Chief Hepatologist at Hospital Sótero de Rio and is part of the Liver Transplant Group and Hepatology Department at Red UC Christus Santiago, Chile. Main clinical interests are in hepatocellular carcinoma and nutrition in liver diseases.
	Dr. Nazia Selzner is a Transplant Hepatologist and Medical Director of Living Donor Liver Transplant t in the Ajmera Transplant Institute, Division of Gastroenterology, University Health Network, and Associate Professor of Medicine at the University of Toronto. Dr. Nazia Selzner is an Associate Scientist at the Institute for Medical Science (IMS) as well as at the Toronto General Research Institute (TGRI). Dr. Selzner graduated from Medical School at the University of Paris VII, France. She completed her Gastroenterology and Hepatology training in 1998 at Clichy Liver Center, Paris, France. She completed her PhD in 2003 at the University of Paris VII, France, after four years of research fellowship at Duke University Medical Center, Durham, NC and at the University of Zurich, Switzerland. Following the completion of her PhD, she has performed a two years clinical fellowship in Liver Transplantation at the Multi-organ Transplant Program, at the University of Toronto. Her research interest is mechanism of hepatic ischemia/reperfusion injury pertaining to fatty and aging liver. Dr Selzner’s main focus is developing protectives strategies against reperfusion of diseased/declined livers based on Ex Vivo Liver Perfusion platform. She is co-Director of Toronto Abdominal Organ Perfusion Laboratories. Her other area of research focus on Access to Liver Transplantation and Living Donor Liver Transplantation based on Ethnoracial and socioeconomic background.

Event Date

Category